SCHEMBL6923683

SCHEMBL6923683

Cc1ccc2c(c1)c1c(O)cccc1n2Cc1ccc(F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.44
P2RX4 Q99571 1/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 2/20 0.44
HTT P42858 1/20 0.44
LMNA P02545 2/20 0.43
MAPT P10636 1/20 0.42
PKM P14618 1/20 0.42
HRH1 P35367 1/20 0.42
HTR6 P50406 1/20 0.42
CACNB4 O00305 1/20 0.41
CACNA1A O00555 1/20 0.41
CACNA1G O43497 1/20 0.41
CACNG3 O60359 1/20 0.41
CACNA1F O60840 1/20 0.41
CACNA1H O95180 1/20 0.41
CACNB3 P54284 1/20 0.41
CACNA2D1 P54289 1/20 0.41
CACNG7 P62955 1/20 0.41
CACNA1B Q00975 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6921048 0.90 HDAC1 (0.43) KDM4EKMT2AMEN1HTTLMNA
SCHEMBL6923659 0.88 KMT2A (0.51) KDM4EP2RX4KMT2AMEN1HTT
SCHEMBL6926577 0.86 MAPT (0.43) KDM4EKMT2AMEN1LMNAMAPT
SCHEMBL6923669 0.83 SRC (0.50) KDM4EP2RX4KMT2AMEN1HTT
SCHEMBL6926616 0.79 LMNA (0.44) KMT2AMEN1LMNAMAPTPLA2G2A
SCHEMBL2156852 0.78 LMNA (0.48) KDM4EKMT2AMEN1HTTLMNA
SCHEMBL6924126 0.77 ESR1 (0.43) KDM4EP2RX4KMT2AMEN1LMNA
SCHEMBL7505287 0.77 ESR1 (0.44) KDM4EKMT2AMEN1MAPTPKM
SCHEMBL6921052 0.75 MEN1 (0.43) KMT2AMEN1HTTLMNAMAPT
SCHEMBL7723992 0.75 SRC (0.53) KDM4EP2RX4KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1169789-C Aminoalkoxy carbazoles for the treatment of CNS diseases 法玛西雅厄普约翰美国公司 2004-10-06 CN disclosed
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
CN-1372547-A Aminoalkoxy carbazoles for the treatment of CNS diseases UPJOHN CO (US) 2002-10-02 CN disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed